Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | 1 | UK110AA | SYR |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | Y014320 | PO / MO |
| UNK | VACCINE NOT SPECIFIED (OTHER) | UNKNOWN MANUFACTURER | 1 | Y017360 | SYR |
On the day of and the days following the vaccine, Patient increasingly vomited and was generally unwell. By October 5 (Sunday), she was increasingly uncomfortable. On October 7 (Tuesday), Patient had very big diarrhea, projective vomited, and was very unwell. That day, she was seen by her pediatrician. In the evening, we went to [withheld] in [withheld] where she was examined and received an IV. The next day, on October 8, Patient was admitted at [withheld] in [withheld] from which she was discharged on October 21. Patient had extreme diarrhea, lost a lot of her body mass, and we had to feed via IV for days before we were able to start her on Pedialite, then powder, until she was able to be fed via bottle again. The symptoms were consistent with a rotavirus infection but Patient tested negative for rotavirus.
Some fuzziness and projectile vomiting prior to and after rotavirus vaccination.
Potential milk/soy allergy.
October 7 -21.